Blog
Latest articles, insights, and updates from the blog.
Psych Deprescribing Debate: What It Means for Ketamine
HHS targets psychiatric overprescribing. Experts say stop what's not working—and replace it with evidence-based alternatives. Here's how ketamine fits in.
CBT After Esketamine Cuts Relapse Risk, Trial Finds
The CBT-ENDURE trial found that pairing esketamine with 16 weeks of CBT reduced suicidal ideation and depression severity better than esketamine alone.
Schizophrenia Survey Reveals Gaps That Echo Across Psychiatry
A new SPAN survey exposes persistent care gaps in schizophrenia treatment. Here's why those findings matter across the broader psychiatric landscape.
Faster TRD Remission: Why Measurement-Based Care Matters
New clinical guidance on TRD emphasizes fast dose adjustments and symptom tracking—here's what it means for patients considering ketamine therapy.
Ketamine Side Effects: What the Data Says on Dropout
New clinical guidance on NMDA antagonist side effects and dropout rates helps patients and providers set realistic expectations for ketamine treatment.
Faster TRD Remission: What Smarter Dosing Means for You
New guidance on treatment-resistant depression stresses faster dose adjustments and symptom tracking. Here's what it means for ketamine therapy patients.
Ketamine Side Effects: What the Data Now Shows
New clinical guidance on NMDA antagonist side effects and discontinuation rates gives ketamine patients a clearer picture of what to expect and when to switch.
Ketamine vs. Esketamine: Side Effects and Who Stops Treatment
New clinical guidance on NMDA antagonist side effects and dropout rates helps patients make smarter choices about ketamine-based depression treatment.
Ketamine Side Effects: What the Data Says in 2026
New clinical guidance on NMDA antagonist side effects and dropout rates helps patients and providers make smarter decisions about ketamine treatment.
Faster TRD Remission: What Measurement-Based Care Means
New guidance on treatment-resistant depression emphasizes faster dose adjustment and symptom tracking—here's why it matters for ketamine patients.
Smarter TRD Care Gets Patients to Remission Faster
New psychiatric guidance on TRD highlights how symptom tracking and dose adjustment speed remission—here's what it means for ketamine patients.
Ketamine for TRD Works Better When Clinics Measure It
New research highlights how symptom tracking and dose optimization help treatment-resistant depression patients reach remission faster with ketamine.
Contact Ketamine Resource
Send corrections, partnership questions, or advertising inquiries.